Corient Private Wealth’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.9M | Buy |
80,704
+39,987
| +98% | +$1.44M | ﹤0.01% | 950 |
|
|
2025
Q1 | $1.61M | Sell |
40,717
-6,661
| -14% | -$263K | ﹤0.01% | 1063 |
|
|
2024
Q4 | $1.43M | Sell |
47,378
-35,309
| -43% | -$1.06M | ﹤0.01% | 1143 |
|
|
2024
Q3 | $1.93M | Sell |
82,687
-15,669
| -16% | -$366K | ﹤0.01% | 1090 |
|
|
2024
Q2 | $1.75M | Buy |
98,356
+25,975
| +36% | +$462K | ﹤0.01% | 1079 |
|
|
2024
Q1 | $1.1M | Sell |
72,381
-21,000
| -22% | -$319K | ﹤0.01% | 1281 |
|
|
2023
Q4 | $1.59M | Buy |
93,381
+65,220
| +232% | +$1.11M | ﹤0.01% | 1104 |
|
|
2023
Q3 | $235K | Buy |
28,161
+10,400
| +59% | +$86.9K | ﹤0.01% | 1841 |
|
|
2023
Q2 | $441K | Buy |
+17,761
| New | +$441K | ﹤0.01% | 1507 |
|